LIFESPHERE® Drug Safety System


The only automated, end-to-end safety system built with the industry, for the industry.

The industry’s most trusted drug safety system just got better.

Developed in partnership with the world’s best life sciences companies, LifeSphere MultiVigilance is an end-to-end, automated safety system that helps hundreds of pharmacovigilance teams around the world save time and effort, ensure future-proof compliance and keep global teams aligned.


Save Time and Effort

Give your PV team more time to focus on what matters most. LifeSphere MultiVigilance uses AI to automate repetitive tasks, enhance decision-making and bring game-changing efficiency to safety workflows.

Future-Proof Compliance

Reduce risk and future-proof your PV environment with a scalable cloud solution that delivers continuous innovation and stays up to date with the latest regulatory requirements.

Aligning Global Teams

Keep global teams aligned with a single cloud database for HQ and affiliates that provides visibility into case management, with multi-language support and worldwide submission readiness.

Learn More About Our Automation Engine


Delivering Real Results to a Global Client Base



Of Top 50 Biopharmas

80% of the top 50 biopharma companies are our clients



Efficiency Gains

80% efficiency gains over legacy systems, driven by our Nava cognitive computing engine



Cost Savings

30% immediate cost savings potential via our advanced automation capabilities




100% compliance with all present and upcoming regulatory standards

The Next-Generation Adverse Event Processing Platform for Life Sciences

LifeSphere MultiVigilance transforms all pharmacovigilance activities with cutting-edge technology
that automates and streamlines key processes.

Pharmacovigilance and Digital Transformation: Stepping into the Technology-Driven Future

The situation created by the pandemic has impacted almost every industry and business domain across the globe, and the pharmacovigilance industry is no exception. With every challenge, however, comes an opportunity to learn and grow.

Presented by Aman Wasan, Senior VP

Regional Pharmacovigilance Regulations

With the increasing global awareness in safety reporting, the volumes of ADRs in MAH/national/global databases are also expected to increase at the same time. To derive meaningful insights from these huge volumes of safety data, it is important that the ADRs obtained from various sources are compiled and collated in a meaningful manner.

How to Select an Automated Drug Safety Platform in Three Steps
Organizations looking to invest in a next-generation Safety system should seek a technology vendor with proven industry knowledge that can deliver a pre-validated solution with true end-to-end automation.

Partnering With the Industry’s Best

Up to 30% Efficiency Gains on Day One

Robotic process automation, natural language processing, and machine learning transform key PV processes, helping companies realize lower costs, faster processing times, higher data quality, and improved compliance.

Seamless Exchange Between Medical Affairs and Safety

LSMV10 offers full unification with product complaint and medical information systems, providing a seamless exchange of safety cases between these critical function.

Unlocking Insights From Safety Data

Reporting and analytics tools, as well as add-on signal detection module, provide for real-time insight into safety data.

Designed for Global Companies

LSMV10 is fully compliant with E2B R3 regulations and a flexible workflow meets the requirements of global regulatory authorities, eliminating the need to deploy region-specific safety solutions. APIs for third-party translation provides customers with the ultimate flexibility to price and contract translation services separately.

Focus on User Experience

A brand new, intuitive user interface simplifies end-user training, while single sign-on functionality allows for easy user authentication.

Simplified IT and Systems Maintenance

LSMV10 is 100% browser-based, enabling rapid implementation and providing seamless upgrades over the cloud.

Advanced technology, such as artificial intelligence and machine learning, are key LifeSphere MultiVigilance capabilities that help us automate repetitive, manual tasks, thus improving efficiency and compliance. By switching to LifeSphere MultiVigilance, our efforts to comply with regulations will be much more efficient.

We have seen how the LifeSphere Platform’s advanced robotic automation and cognitive features will allow us to automate many of our key, resource-intensive PV steps in the area of case processing”.

Claudia Lehmann

Head of Pharmacovigilance Operations, Boehringer Ingelheim